GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED;ASTEX THERAPEUTICS LIMITED
发明人:
KERNS, Jeffrey K,CALLAHAN, James Francis,YAN, Hongxing,HEIGHTMAN, Thomas Daniel,GRIFFITHS-JONES, Charlotte Mary,WOOLFORD, Alison Jo-Anne,LI, Tindy,LAKDAWALA SHAH, Ami,DAVIS, Roderic S.,NORTON, David,G,KERNS JEFFREY K,CALLAHAN JAMES FRANCIS,YAN HONGXING,HEIGHTMAN THOMAS DANIEL,GRIFFITHS-JO
申请号：
CL2017003226
公开号：
CL2017003226A1
申请日:
2017.12.15
申请国别(地区):
CL
年份:
2018
代理人:
摘要：
<； p >； compounds derived from phenyl Pyridine or pyrazine regulators, Pharmaceutical composition； Nrf2； Treatment method； and use for treating Asthma, COPD, pulmonary fibrosis, acute infection,Atherosclerosis, hypertension, Heart Failure, myocardial infarction, Parkinson's disease, Alzheimer's disease, among others. <； / p >；<；p>；COMPUESTOS DERIVADOS DE FENILO, PIRIDINA O PIRAZINA, REGULADORES DE NRF2； COMPOSICION FARMACEUTICA； METODO DE TRATAMIENTO； Y USO PARA TRATAR EPOC, ASMA, FIBROSIS, INFECCION PULMONAR AGUDA, ATEROSCLEROSIS, HIPERTENSIÓ；N, INSUFICIENCIA CARDÍ；ACA, INFARTO DE MIOCARDIO, ENFERMEDAD DE PARKINSON, ENFERMEDAD DE ALZHEIMER, ENTRE OTROS.<；/p>；
